Difference between revisions of "Substance FHIR Resource Proposal"
(Created page with "{{subst::Template:FHIR Resource Proposal}}") |
|||
(13 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | |||
<div class="messagebox cleanup metadata"> | <div class="messagebox cleanup metadata"> | ||
<div style="float: left;">[[Image:OpenHotTopic.GIF|35px| ]]</div> | <div style="float: left;">[[Image:OpenHotTopic.GIF|35px| ]]</div> | ||
<div style="background:#F0F0F0"> | <div style="background:#F0F0F0"> | ||
− | This page documents | + | This page documents an [[:category:Approved FHIR Resource Proposal|Approved]] [[:category:FHIR Resource Proposal|FHIR Resource Proposal]] |
</div> | </div> | ||
</div> | </div> | ||
[[Category:FHIR Resource Proposal]] | [[Category:FHIR Resource Proposal]] | ||
− | [[Category: | + | [[Category:Approved FHIR Resource Proposal]] |
Line 13: | Line 12: | ||
− | = | + | =Substance= |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Owning committee name== | ==Owning committee name== | ||
− | + | [[Orders & Observations WG]] | |
− | [[ | ||
==Interested Work Groups== | ==Interested Work Groups== | ||
− | + | * Anatomic Pathology | |
− | * | + | * Clinical Genomics |
− | * | + | * Imaging Integration |
− | * | + | * Pharmacy |
+ | * Public Health and Emergency Response | ||
==FHIR Resource Development Project Insight ID== | ==FHIR Resource Development Project Insight ID== | ||
− | + | 952 | |
==Scope of coverage== | ==Scope of coverage== | ||
Line 55: | Line 42: | ||
As a rule, resources should encompass all of these aspects. | As a rule, resources should encompass all of these aspects. | ||
--> | --> | ||
+ | |||
+ | DEFINITION (SUBSTANCE): | ||
+ | This resource will cover data elements, structures and relationships required to uniquely define and identify substances and specified substances within medicinal products or used for medicinal purposes, dietary supplements, food and feed additives, cosmetics, etc. | ||
+ | |||
+ | Any material is a substance. Substances come in a wide variety of physical forms and can pass through different states (ie. Gas, liquid, solid) while still retaining their physical composition and material characteristics. | ||
+ | |||
+ | Examples: Pharmaceutical substances, disposable supplies, durable equipment, implantable devices, food items, waste, traded goods | ||
+ | |||
+ | Substance is used when the focus is the material as opposed to the source of the material and the processing done on it - in which case Specimen is more appropriate. | ||
==RIM scope== | ==RIM scope== | ||
<!-- Identify the formal RIM mapping for the root concept of the resource. The expectation is that the RIM mapping will be sufficiently precise so as to not overlap with any other resource definition. --> | <!-- Identify the formal RIM mapping for the root concept of the resource. The expectation is that the RIM mapping will be sufficiently precise so as to not overlap with any other resource definition. --> | ||
+ | Entity: Material (EntityClass="MAT") | ||
==Resource appropriateness== | ==Resource appropriateness== | ||
Line 74: | Line 71: | ||
* Have the characteristics of high cohesion & low coupling – need to explore whether coupling is good some places, not elsewhere – layers from Bo’s document | * Have the characteristics of high cohesion & low coupling – need to explore whether coupling is good some places, not elsewhere – layers from Bo’s document | ||
--> | --> | ||
+ | In healthcare, substances are used to treat patients, substances are analyzed for diagnostic, treatment, and research, subjects come in contact with certain substance thereby causing a need for healthcare, and so forth. | ||
==Expected implementations== | ==Expected implementations== | ||
<!-- For resources not deemed "key", what interest is there by implementers in using this particular resource. (Should ideally have multiple independent implementations) --> | <!-- For resources not deemed "key", what interest is there by implementers in using this particular resource. (Should ideally have multiple independent implementations) --> | ||
+ | |||
+ | Commonly as part of the use of other resources - such as MedicationPrescription or MedicationAdministration. A substance might also be related to dietary observations or adverse reactions. | ||
==Content sources== | ==Content sources== | ||
Line 84: | Line 84: | ||
Are there any source specifications that you wish to consult but are concerned about access to or expertise to consider? --> | Are there any source specifications that you wish to consult but are concerned about access to or expertise to consider? --> | ||
+ | |||
+ | *HL7 v3 Laboratory Standard - Normative | ||
+ | *HL7 v3 IDMP Standard | ||
+ | *HL7 v2.x | ||
+ | *openEhr archetypes | ||
+ | |||
+ | ==Example Scenarios== | ||
+ | * A person believes that their hayfever is an allergy to pollen. An allergy test is performed using a number of different substances to determine if there is a specific cause. | ||
+ | * A clinician has a specific 'recipe' for a wart treatment. This involves the creation of a solution form a number of different substances, not all of which are coded in commonly user terminologies. | ||
+ | |||
==Resource Relationships== | ==Resource Relationships== | ||
Line 95: | Line 105: | ||
Reference to resources is really only relevant at the "same or higher level" (Bo – fix this wording) | Reference to resources is really only relevant at the "same or higher level" (Bo – fix this wording) | ||
--> | --> | ||
+ | *Order | ||
+ | *DiagnosticOrder | ||
+ | *DiagnosticReport | ||
+ | *ImagingStudy | ||
+ | *Medication | ||
+ | *Supply | ||
+ | *Device | ||
+ | *AdverseReaction | ||
==Timelines== | ==Timelines== | ||
<!-- Indicate the target date for having the resource complete from a committee perspective and ready for vetting and voting --> | <!-- Indicate the target date for having the resource complete from a committee perspective and ready for vetting and voting --> | ||
+ | |||
+ | *Approved by OO WG: May 2013 WGM | ||
+ | *Planned Ballot: September 2013 | ||
==gForge Users== | ==gForge Users== | ||
<!-- Identify the userids who will require commit access to gForge to maintain the resource. (Ensure all users have registered for gForge.) --> | <!-- Identify the userids who will require commit access to gForge to maintain the resource. (Ensure all users have registered for gForge.) --> | ||
+ | *Lorraine Constable | ||
+ | *Patrick Loyd | ||
+ | |||
+ | ==Issues== | ||
+ | * Scope Challenge: When to use substance vs medication. Medication is a subtype of substance. Also need to come up with better differentiation between this and Specimen | ||
+ | * Need explanation of relations to other resources |
Latest revision as of 05:51, 22 May 2014
Contents
- 1 Substance
- 1.1 Owning committee name
- 1.2 Interested Work Groups
- 1.3 FHIR Resource Development Project Insight ID
- 1.4 Scope of coverage
- 1.5 RIM scope
- 1.6 Resource appropriateness
- 1.7 Expected implementations
- 1.8 Content sources
- 1.9 Example Scenarios
- 1.10 Resource Relationships
- 1.11 Timelines
- 1.12 gForge Users
- 1.13 Issues
Substance
Owning committee name
Interested Work Groups
- Anatomic Pathology
- Clinical Genomics
- Imaging Integration
- Pharmacy
- Public Health and Emergency Response
FHIR Resource Development Project Insight ID
952
Scope of coverage
DEFINITION (SUBSTANCE): This resource will cover data elements, structures and relationships required to uniquely define and identify substances and specified substances within medicinal products or used for medicinal purposes, dietary supplements, food and feed additives, cosmetics, etc.
Any material is a substance. Substances come in a wide variety of physical forms and can pass through different states (ie. Gas, liquid, solid) while still retaining their physical composition and material characteristics.
Examples: Pharmaceutical substances, disposable supplies, durable equipment, implantable devices, food items, waste, traded goods
Substance is used when the focus is the material as opposed to the source of the material and the processing done on it - in which case Specimen is more appropriate.
RIM scope
Entity: Material (EntityClass="MAT")
Resource appropriateness
In healthcare, substances are used to treat patients, substances are analyzed for diagnostic, treatment, and research, subjects come in contact with certain substance thereby causing a need for healthcare, and so forth.
Expected implementations
Commonly as part of the use of other resources - such as MedicationPrescription or MedicationAdministration. A substance might also be related to dietary observations or adverse reactions.
Content sources
- HL7 v3 Laboratory Standard - Normative
- HL7 v3 IDMP Standard
- HL7 v2.x
- openEhr archetypes
Example Scenarios
- A person believes that their hayfever is an allergy to pollen. An allergy test is performed using a number of different substances to determine if there is a specific cause.
- A clinician has a specific 'recipe' for a wart treatment. This involves the creation of a solution form a number of different substances, not all of which are coded in commonly user terminologies.
Resource Relationships
- Order
- DiagnosticOrder
- DiagnosticReport
- ImagingStudy
- Medication
- Supply
- Device
- AdverseReaction
Timelines
- Approved by OO WG: May 2013 WGM
- Planned Ballot: September 2013
gForge Users
- Lorraine Constable
- Patrick Loyd
Issues
- Scope Challenge: When to use substance vs medication. Medication is a subtype of substance. Also need to come up with better differentiation between this and Specimen
- Need explanation of relations to other resources